AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 293: F938-F945, 2007. First published July 18, 2007; doi:10.1152/ajprenal.00146.2007
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/3/F938    most recent
00146.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobori, H.
Right arrow Articles by Navar, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobori, H.
Right arrow Articles by Navar, L. G.

Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice

Hiroyuki Kobori,1 Yuri Ozawa,1 Ryousuke Satou,1 Akemi Katsurada,1 Kayoko Miyata,1 Naro Ohashi,1 Naoki Hase,1 Yuki Suzaki,1 Curt D. Sigmund,2 and L. Gabriel Navar1

1Department of Physiology, and Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans, Louisiana; and 2Departments of Medicine and Physiology and Biophysics, University of Iowa, Iowa City, Iowa

Submitted 28 March 2007 ; accepted in final form 9 July 2007

This study was performed in transgenic mice to test the hypothesis that the selective intrarenal overproduction of ANG II increases intrarenal mouse (m) angiotensinogen (AGT) expression. We used the following three groups: 1) single transgenic mice (group A, n = 14) expressing human (h) AGT only in the kidney, 2) double-transgenic mice (group D, n = 13) expressing human renin systemically in addition to hAGT only in the kidney, and 3) wild-type (group W, n = 12) mice. Exogenous hAGT protein is inactive in group A because endogenous mouse renin cannot cleave hAGT to ANG I because of a high species specificity. All mice were monitored from 12 to 18 wk of age. Systolic blood pressure progressively increased from 116 ± 5 mmHg (12 wk) to 140 ± 7 (18 wk) in group D. This increase was not observed in groups A or W. Intrarenal hAGT levels were similar in groups A and D; however, hAGT was not detectable in kidneys of group W. Kidney ANG II levels were increased in group D (216 ± 43 fmol/g) compared with groups A (117 ± 16) and W (118 ± 17). However, plasma ANG II concentrations were similar among the three groups. Endogenous renal mAGT mRNA was increased significantly in group D (1.46 ± 0.19, ratio) compared with groups A (0.97 ± 0.12) and W (1.00 ± 0.08). Endogenous renal mAGT protein was also significantly increased in group D compared with groups A and W. Interstitial collagen-positive area, interstitial macrophage/monocyte infiltration, and afferent arteriolar wall thickness were increased significantly in group D compared with groups A and W. These data indicate for the first time that the selective stimulation of intrarenal production of ANG II from hAGT augments endogenous intrarenal mAGT mRNA and protein expression.

hypertension; transgenic mouse; angiotensin II; renal injury



Address for reprint requests and other correspondence: H. Kobori, Tulane Univ. Health Sciences Center, 1430 Tulane Ave., #SL39, New Orleans, LA 70112-2699 (e-mail: hkobori{at}tulane.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
R. A. Gonzalez-Villalobos, D. M. Seth, R. Satou, H. Horton, N. Ohashi, K. Miyata, A. Katsurada, D. V. Tran, H. Kobori, and L. G. Navar
Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F772 - F779.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Satou, R. A. Gonzalez-Villalobos, K. Miyata, N. Ohashi, A. Katsurada, L. G. Navar, and H. Kobori
Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F283 - F289.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
H. M. Siragy and J. Huang
Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity
Exp Physiol, May 1, 2008; 93(5): 709 - 714.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M. J. Soler, J. Wysocki, and D. Batlle
Angiotensin-converting enzyme 2 and the kidney
Exp Physiol, May 1, 2008; 93(5): 549 - 556.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Kobori, A. Katsurada, K. Miyata, N. Ohashi, R. Satou, T. Saito, Y. Hagiwara, K. Miyashita, and L. G. Navar
Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1257 - F1263.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.